Latest & greatest articles for magnesium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on magnesium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on magnesium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for magnesium

121. Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis (Full text)

Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis Ho K M, Sheridan D J, Paterson T CRD summary This well-conducted review found that intravenous magnesium is not effective in converting acute onset atrial fibrillation to sinus rhythm in patients with a normal serum magnesium (...) concentration. The addition of intravenous magnesium to digoxin reduces fast ventricular response rates, but is less effective than other calcium antagonists or amiodarone. These findings are likely to be reliable. Authors' objectives To determine the effectiveness of intravenous magnesium in the conversion of acute onset atrial fibrillation (AF) to sinus rhythm, and in reducing ventricular response and risk of bradycardia. Searching The Cochrane CENTRAL Register, EMBASE and MEDLINE were searched to May

2007 DARE. PubMed

122. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis

Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

123. Magnesium for acute traumatic brain injury. (PubMed)

Magnesium for acute traumatic brain injury. Acute traumatic brain injury is a leading cause of death and disability in young adults. Magnesium had been considered as a potential therapeutic tool because of its activity on NMDA-receptors, calcium channels and neuron membranes. Animals studies have indicated a beneficial effect of magnesium on outcome after brain injury, but its efficacy in humans is unknown.To quantify the effect of magnesium administration on mortality and morbidity in patients (...) with acute traumatic brain injury.We searched the Cochrane Injuries Group's specialised register, Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, National Research Register, Current Controlled Trials, SIGLE, LILACS, Zetoc. The searches were conducted in July 2005.We included all randomized controlled trials comparing any magnesium salt with no magnesium or with placebo, in patients following acute traumatic brain injury.Two authors independently screened search results and assessed

2006 Cochrane

124. ED use of magnesium sulphate improved rate control in atrial fibrillation with rapid ventricular response (Full text)

ED use of magnesium sulphate improved rate control in atrial fibrillation with rapid ventricular response ED use of magnesium sulphate improved rate control in atrial fibrillation with rapid ventricular response | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here ED use of magnesium sulphate improved rate control in atrial fibrillation with rapid ventricular response Article Text Therapeutics ED use of magnesium sulphate improved rate

2006 Evidence-Based Medicine (Requires free registration) PubMed

125. Pantoprazole magnesium

Pantoprazole magnesium Common Drug Review CEDAC Meeting – June 21, 2006 Page 1 of 2 Notice of CEDAC Final Recommendation – July 20, 2006 CEDAC FINAL RECOMMENDATION and REASONS for RECOMMENDATION PANTOPRAZOLE MAGNESIUM (Pantoloc M™ – Altana Pharma Inc.) Description: Pantoprazole magnesium is a new salt form of pantoprazole, a widely used proton pump inhibitor (PPI). It is approved for use in conditions where a reduction of gastric acid is required, such as the following: duodenal ulcer, gastric (...) ulcer, reflux esophagitis and symptomatic gastro- esophageal reflux disease (such as, acid regurgitation and heartburn). Additionally, pantoprazole, in combination with clarithromycin and either amoxicillin or metronidazole, is approved for use in the treatment of patients with an active duodenal ulcer who are H. pylori positive. Dosage Forms: 40 mg enteric coated tablet Recommendation: The Canadian Expert Drug Advisory Committee (CEDAC) recommends that pantoprazole magnesium be listed in a similar

2006 Canadian Agency for Drugs and Technologies in Health - Common Drug Review

126. Magnesium supplementation for the management of essential hypertension in adults. (PubMed)

Magnesium supplementation for the management of essential hypertension in adults. Epidemiological evidence on the effects of magnesium on blood pressure is inconsistent. Metabolic and experimental studies suggest that magnesium may have a role in the regulation of blood pressure.To evaluate the effects of magnesium supplementation as treatment for primary hypertension in adults.We searched the Cochrane Library, MEDLINE, EMBASE, Science Citation Index, ISI Proceedings, ClinicalTrials.gov (...) , Current Controlled Trials, CAB abstracts, and reference lists of systematic reviews, meta-analyses and randomised controlled trials (RCTs) included in the review.Inclusion criteria were: 1) RCTs of a parallel or crossover design comparing oral magnesium supplementation with placebo, no treatment, or usual care; 2) treatment and follow-up >/=8 weeks; 3) participants over 18 years old, with raised systolic blood pressure (SBP) >/=140 mmHg or diastolic blood pressure (DBP) >/=85 mmHg; 4) SBP and DBP

2006 Cochrane

127. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. (PubMed)

Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Previous research suggests that increasing dietary intakes of calcium, potassium or magnesium separately may reduce BP to a small degree over the short term. It is unclear whether increasing intakes of a combination of these minerals produces a larger reduction in BP.To evaluate the effects of combined mineral supplementation as a treatment for primary hypertension in adults.We (...) searched the Cochrane Library, MEDLINE, EMBASE, Science Citation Index, ISI Proceedings, ClinicalTrials.gov, Current Controlled Trials, CAB abstracts, and reference lists of systematic reviews, meta-analyses and randomised controlled trials (RCTs) included in the review. The search was unrestricted by language or publication status.Inclusion criteria were: 1) RCTs of a parallel or crossover design comparing oral supplements comprising a combination of potassium, and/or calcium, and/or magnesium

2006 Cochrane

128. Review: magnesium prophylaxis after cardiac surgery reduces the risk of arrhythmia and atrial fibrillation (Full text)

Review: magnesium prophylaxis after cardiac surgery reduces the risk of arrhythmia and atrial fibrillation Review: magnesium prophylaxis after cardiac surgery reduces the risk of arrhythmia and atrial fibrillation | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: magnesium prophylaxis after cardiac surgery reduces the risk of arrhythmia and atrial fibrillation Article Text Treatment Review: magnesium prophylaxis after cardiac

2006 Evidence-Based Nursing PubMed

129. Intravenous magnesium in shock resistant tachyarrhythmias

Intravenous magnesium in shock resistant tachyarrhythmias BestBets: Intravenous Magnesium in shock-resistant tachyarrhythmias Intravenous Magnesium in shock-resistant tachyarrhythmias Report By: Ayan Sen - Senior House Officer, Anaesthetics and Intensive Care Search checked by Shweta Gidwani - Clinical Effectiveness Fellow Institution: Fairfield Hospital,Bury Date Submitted: 21st December 2005 Date Completed: 1st March 2006 Last Modified: 21st December 2005 Status: Green (complete) Three Part (...) Question Does [intravenous magnesium] lead to [return of spontaneous circulation] in [shock-resistant tachyarrhythmias] Clinical Scenario A 65 year old man suffered a witnessed out-of-hospital cardiac arrest. He received 20 minutes of basic and advances cardiac life support measures in the field. On arrival in the emergency department, the rhythm showed persistent ventricular fibrillation and he continued to be pulseless. You decide to continue another cycle of defibrillation and think of anti

2006 BestBETS

130. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. (PubMed)

Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. The most common cause of death in individuals with severe tetanus in the absence of mechanical ventilation is spasm-related respiratory failure, whereas in ventilated patients it is tetanus-associated autonomic dysfunction. Our aim was to determine whether continuous magnesium sulphate infusion reduces the need for mechanical ventilation and improves control of muscle spasms and autonomic instability.We did (...) a randomised, double blind, placebo controlled trial in 256 Vietnamese patients over age 15 years with severe tetanus admitted to the Hospital for Tropical Medicine, Ho Chi Minh City, Vietnam. Participants were randomly assigned magnesium sulphate (n=97) or placebo solution (n=98) intravenously for 7 days. The primary outcomes were requirement of assisted ventilation and of drugs to control muscle spasms and cardiovascular instability within the 7-day study period. Analyses were done by intention to treat

2006 Lancet

131. Nebulized magnesium sulfate in the management of acute exacerbations of asthma

Nebulized magnesium sulfate in the management of acute exacerbations of asthma Nebulized magnesium sulfate in the management of acute exacerbations of asthma Nebulized magnesium sulfate in the management of acute exacerbations of asthma Villeneuve E J, Zed P J CRD summary This review concluded that there was insufficient evidence to determine the role of nebulised magnesium sulphate in the treatment of acute exacerbations of asthma. The review had methodological limitations (limited search (...) and no validity assessment) and only six small studies were included. However, the authors' cautious conclusions, and their recommendation for further research, appear appropriate. Authors' objectives To evaluate the efficacy and safety of nebulised magnesium sulphate (NMS) for treating acute exacerbations of asthma. Searching MEDLINE/PubMed and EMBASE were searched to October 2005; the search terms were reported. The searches were restricted to publications in the English language. Abstracts were excluded

2006 DARE.

132. The Magic of Magnesium as an Adjunct in Atrial Fibrillation

The Magic of Magnesium as an Adjunct in Atrial Fibrillation The Magic of Magnesium as an Adjunct in Atrial Fibrillation « Sinai EM Journal Club Emergency Medicine Discussion Forum The Magic of Magnesium as an Adjunct in Atrial Fibrillation Dinali did a stellar job this month at Journal Club; not only was her talk thought-provoking and clinically relevant, but I learned more about the history of of than I would have ever thought possible. This month’s JC was primarily about Davey and Teubner’s (...) AEM paper on using Magnesium sulfate as an adjunct to “usual care” for rate control in atrial fibrillation ( ). We also touched upon some data from an all-Greek study in the Int’l Journal of Cardiology on Mg alone vs diltiazem alone in A-fib ( ). Davey and Taubner looked at 199 Australians with rapid afib in this prospective, randomized, double-blinded, placebo-controlled trial. They got “standard rate-reduction agents” plus placebo, or te same agents plus 20 mEq of magnesium sulfate infused over

2006 Sinai EM Journal Club

133. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials

Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

134. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial

Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.

135. Combined vitamin B6-magnesium treatment in autism spectrum disorder. (PubMed)

Combined vitamin B6-magnesium treatment in autism spectrum disorder. The use of mega-vitamin intervention began in the 1950s with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with "autism syndrome" when speech and language improvement was observed in some children as a result of large doses of B6. A number of studies attempted to assess the effects of vitamin B6-Magnesium (Mg) was found to reduce undesirable side effects from B6 (...) ) on characteristics such as verbal communication, non-verbal communication, interpersonal skills, and physiological function, in individuals with autism.To determine the efficacy of vitamin B6 and magnesium (B6-Mg) for treating social, communication, and behavioural responses of children and adults with autism.We searched the Cochrane Controlled Trials Register (Cochrane Library, Issue 2, 2002), MEDLINE (1966 to January 2002), EMBASE (1980 to January 2002), PsycINFO (1887 to January 2002), Dissertation Abstracts

2005 Cochrane

136. Does magnesium offer any additional benefit in patients having anti-arrhythmic treatment for atrial fibrillation following cardiac surgery?

Does magnesium offer any additional benefit in patients having anti-arrhythmic treatment for atrial fibrillation following cardiac surgery? BestBets: Does magnesium offer any additional benefit in patients having anti-arrhythmic treatment for atrial fibrillation following cardiac surgery? Does magnesium offer any additional benefit in patients having anti-arrhythmic treatment for atrial fibrillation following cardiac surgery? Report By: Anish Patel, Jagan Rao - Cardiothoracic Registrars Search (...) checked by J Desmond - Cardiothoracic Registrar RCS Institution: Department of Cardiothoracic Surgery, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne Date Submitted: 15th April 2003 Date Completed: 29th July 2005 Last Modified: 6th May 2003 Status: Green (complete) Three Part Question In [patients undergoing cardiac surgery, going into atrial fibrillation] is [the addition of magnesium] more effective than standard therapy alone in [cardioverting or controlling ventricular rate]. Clinical

2005 BestBETS

137. Magnesium intake in relation to risk of colorectal cancer in women. (Full text)

Magnesium intake in relation to risk of colorectal cancer in women. Animal studies have suggested that dietary magnesium may play a role in the prevention of colorectal cancer, but data in humans are lacking.To evaluate the hypothesis that a high magnesium intake reduces the risk of colorectal cancer in women.The Swedish Mammography Cohort, a population-based prospective cohort of 61,433 women aged 40 to 75 years without previous diagnosis of cancer at baseline from 1987 to 1990.Incident (...) invasive colorectal cancer.During a mean of 14.8 years (911 042 person-years) of follow-up, 805 incident colorectal cancer cases were diagnosed. After adjustment for potential confounders, we observed an inverse association of magnesium intake with the risk of colorectal cancer (P for trend = .006). Compared with women in the lowest quintile of magnesium intake, the multivariate rate ratio (RR) was 0.59 (95% confidence interval [CI], 0.40-0.87) for those in the highest quintile. The inverse association

2005 JAMA PubMed

138. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis

Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

139. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

140. A meta-analysis on intravenous magnesium sulphate for treating acute asthma

A meta-analysis on intravenous magnesium sulphate for treating acute asthma Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.